journal article·2024-03Open access

Peptide-mimicking poly(2-oxazoline)s as adjuvants to enhance activities and antibacterial spectrum of polymyxin B

Zhengjie Luo, Xuebin Zhao, Min Zhou, Jingcheng Zou, Ximian Xiao, Longqiang Liu, Jiayang Xie, Yueming Wu, Wenjing Zhang, Runhui Liu

Science China Materials· Volume 67· Issue 3

Abstract

临床上常用的广谱抗生素无法有效解决抗生素高度耐药ESKAPE菌感染的难题, ESKAPE耐药菌已经成为人类生命健康的重大威胁. 抗生素与佐剂的联合治疗是解决抗生素耐药菌感染的重要途径, 但是探索对所有ESKAPE耐药菌都具有广谱和高效抗菌活性的抗生素-佐剂组合仍然面临巨大挑战. 在这里, 我们提出了一种抗生素-佐剂的有效设计策略, 将对ESKAPE中耐药阴性菌具有高活性的多粘菌素B(PMB)与模拟宿主防御肽的细菌膜靶向阳离子聚(2-噁唑啉)相结合. 我们通过2-噁唑啉单体可控聚合, 合成了一系列具有不同疏水性侧链的阳离子聚(2-噁唑啉). 研究表明, 聚(2-噁唑啉)和PMB的组合效果随着聚(2-噁唑啉)侧链疏水性的提高呈现出从拮抗效应到协同效应的逐渐变化. 其中, 优选的聚(2-噁唑啉) EACA-POX20显著增强了PMB的抗菌活性, 尤其是对于ESKAPE耐药阳性菌的抗菌活性增强了16–32倍. 聚(2-噁唑啉) EACA-POX20有效增强了PMB的抗菌活性并扩展了PMB的抗菌谱. 聚(2-噁唑啉)和PMB的组合策略能够有效对抗所有耐药ESKAPE病原体, 为解决ESKAPE耐药菌提供了新的思路.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Antimicrobial agents and applications · Antimicrobial Peptides and Activities · Biopolymer Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Larsson DGJ, Flach CF. Antibiotic resistance in the environment. Nat Rev Microbiol, 2021, 20: 257–26910.1038/s41579-021-00649-x ↗
2. Zhang D, Qian Y, Zhang S, et al. Alpha-beta chimeric polypeptide molecular brushes display potent activity against superbugs-methicillin resistant Staphylococcus aureus. Sci China Mater, 2018, 62: 604–61010.1007/s40843-018-9351-x ↗
3. Sun J, Ma X, Li R, et al. Antimicrobial nanostructured assemblies with extremely low toxicity and potent activity to eradicate Staphylococcus aureus biofilms. Small, 2023, 19: 220403910.1002/smll.202204039 ↗
4. Zhou W, Jiang X, Zhen X. Development of organic photosensitizers for antimicrobial photodynamic therapy. BioMater Sci, 2023, 11: 5108–512810.1039/D3BM00730H ↗
5. De Oliveira DMP, Forde BM, Kidd TJ, et al. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev, 2020, 33: e00181–19
6. Tommasi R, Brown DG, Walkup GK, et al. Erratum: ESKAPEing the labyrinth of antibacterial discovery. Nat Rev Drug Discov, 2015, 14: 66210.1038/nrd4729 ↗
7. Wiman E, Zattarin E, Aili D, et al. Development of novel broad-spectrum antimicrobial lipopeptides derived from plantaricin NC8 β. Sci Rep, 2023, 13: 410410.1038/s41598-023-31185-8 ↗
8. Ghosh C, Sarkar P, Issa R, et al. Alternatives to conventional antibiotics in the era of antimicrobial resistance. Trends Microbiol, 2019, 27: 323–33810.1016/j.tim.2018.12.010 ↗
9. Duan S, Wu R, Xiong YH, et al. Multifunctional antimicrobial materials: From rational design to biomedical applications. Prog Mater Sci, 2022, 125: 10088710.1016/j.pmatsci.2021.100887 ↗
10. Ji S, Zhou S, Zhang X, et al. An oxygen-sensitive probe and a hydrogel for optical imaging and photodynamic antimicrobial chemotherapy of chronic wounds. BioMater Sci, 2022, 10: 2054–206110.1039/D2BM00153E ↗
11. Zhang X, Qi S, Duan X, et al. Clinical outcomes and safety of polymyxin B in the treatment of carbapenem-resistant Gram-negative bacterial infections: A real-world multicenter study. J Transl Med, 2021, 19: 43110.1186/s12967-021-03111-x ↗
12. Trimble MJ, Mlynárčik P, Kolář M, et al. Polymyxin: Alternative mechanisms of action and resistance. Cold Spring Harb Perspect Med, 2016, 6: a02528810.1101/cshperspect.a025288 ↗
13. Mohapatra SS, Dwibedy SK, Padhy I. Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions. J Biosci, 2021, 46: 8510.1007/s12038-021-00209-8 ↗
14. Velkov T, Thompson PE, Nation RL, et al. Structure-activity relationships of polymyxin antibiotics. J Med Chem, 2009, 53: 1898–191610.1021/jm900999h ↗
15. Yin J, Meng Q, Cheng D, et al. Mechanisms of bactericidal action and resistance of polymyxins for Gram-positive bacteria. Appl Microbiol Biotechnol, 2020, 104: 3771–378010.1007/s00253-020-10525-y ↗
16. Vinci MC, Vattimo MdFF, Watanabe M, et al. Polymyxin B nephrotoxicity: From organ to cell damage. PLoS One, 2016, 11: e016105710.1371/journal.pone.0161057 ↗
17. Moubareck CA. Polymyxins and bacterial membranes: A review of antibacterial activity and mechanisms of resistance. Membranes, 2020, 10: 18110.3390/membranes10080181 ↗
18. Li Y, Deng Y, Zhu ZY, et al. Population pharmacokinetics of polymyxin B and dosage optimization in renal transplant patients. Front Pharmacol, 2021, 12: 72717010.3389/fphar.2021.727170 ↗
19. Kelesidis T, Falagas ME. The safety of polymyxin antibiotics. Expert Opin Drug Saf, 2015, 14: 1687–170110.1517/14740338.2015.1088520 ↗
20. Su M, Wang M, Hong Y, et al. Polymyxin derivatives as broad-spectrum antibiotic agents. Chem Commun, 2019, 55: 13104–1310710.1039/C9CC06908A ↗
21. Ekladious I, Colson YL, Grinstaff MW. Polymer–drug conjugate therapeutics: Advances, insights and prospects. Nat Rev Drug Discov, 2019, 18: 273–29410.1038/s41573-018-0005-0 ↗
22. Dhanda G, Acharya Y, Haldar J. Antibiotic adjuvants: A versatile approach to combat antibiotic resistance. ACS Omega, 2023, 8: 10757–1078310.1021/acsomega.3c00312 ↗
23. Chen C, Shi J, Wang D, et al. Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens. Crit Rev Microbiol, 2023, 1–1810.1080/1040841X.2023.2186215 ↗
24. Mu S, Zhu Y, Wang Y, et al. Cationic polysaccharide conjugates as antibiotic adjuvants resensitize multidrug-resistant bacteria and prevent resistance. Adv Mater, 2022, 34: 220406510.1002/adma.202204065 ↗
25. Romanovska A, Keil J, Tophoven J, et al. Conjugates of ciprofloxacin and amphiphilic block copoly(2-alkyl-2-oxazolines)s overcome efflux pumps and are active against CIP-resistant bacteria. Mol Pharm, 2021, 18: 3532–354310.1021/acs.molpharmaceut.1c00430 ↗
26. Zhao X, Liu S, Jiang X. Leveraging bimetallic nanoparticles to synergistically enhance the efficacy of antibiotics against carbapenem-resistant bacteria. Sci China Mater, 2023, 66: 2885–289210.1007/s40843-022-2459-3 ↗
27. Ding X, Yang C, Moreira W, et al. A macromolecule reversing antibiotic resistance phenotype and repurposing drugs as potent antibiotics. Adv Sci, 2020, 7: 200137410.1002/advs.202001374 ↗
28. Liu Z, Zhao X, Yu B, et al. Rough carbon–iron oxide nanohybrids for near-infrared-II light-responsive synergistic antibacterial therapy. ACS Nano, 2021, 15: 7482–749010.1021/acsnano.1c00894 ↗
29. Bernal P, Molina-Santiago C, Daddaoua A, et al. Antibiotic adjuvants: Identification and clinical use. Microb Biotechnol, 2013, 6: 445–44910.1111/1751-7915.12044 ↗
30. Zhao H, Zhong L, Yang C, et al. Antibiotic–polymer self-assembled nanocomplex to reverse phenotypic resistance of bacteria toward lastresort antibiotic colistin. ACS Nano, 2023, 17: 15411–1542310.1021/acsnano.3c00981 ↗
31. Xie J, Zhou M, Qian Y, et al. Addressing MRSA infection and antibacterial resistance with peptoid polymers. Nat Commun, 2021, 12: 589810.1038/s41467-021-26221-y ↗
32. Xiao X, Zhou M, Cong Z, et al. Controllable polymerization of N-substituted β-alanine N-thiocarboxyanhydrides for convenient synthesis of functional poly(β-peptoid)s. CCS Chem, 2023, 5: 994–100410.31635/ccschem.022.202201840 ↗
33. Yu H, Liu L, Li X, et al. Fabrication of polylysine based antibacterial coating for catheters by facile electrostatic interaction. Chem Eng J, 2019, 360: 1030–104110.1016/j.cej.2018.10.160 ↗
34. Shi Z, Zhang X, Yu Z, et al. Facile synthesis of imidazolium-based block copolypeptides with excellent antimicrobial activity. Biomacromolecules, 2021, 22: 2373–238110.1021/acs.biomac.1c00126 ↗
35. Shen W, He P, Xiao C, et al. From antimicrobial peptides to antimicrobial poly(α-amino acid)s. Adv Healthcare Mater, 2018, 7: 180035410.1002/adhm.201800354 ↗
36. Sun J, Li M, Lin M, et al. High antibacterial activity and selectivity of the versatile polysulfoniums that combat drug resistance. Adv Mater, 2021, 33: 210440210.1002/adma.202104402 ↗
37. Teng R, Yang Y, Zhang Z, et al. In situ enzyme-induced self-assembly of antimicrobial-antioxidative peptides to promote wound healing. Adv Funct Mater, 2023, 33: 221445410.1002/adfm.202214454 ↗
38. Wu Y, Zhang D, Ma P, et al. Lithium hexamethyldisilazide initiated superfast ring opening polymerization of alpha-amino acid N-carboxyanhydrides. Nat Commun, 2018, 9: 529710.1038/s41467-018-07711-y ↗
39. Sang P, Shi Y, Huang B, et al. Sulfono-γ-AApeptides as helical mimetics: Crystal structures and applications. Acc Chem Res, 2020, 53: 2425–244210.1021/acs.accounts.0c00482 ↗
40. Zhou M, Zou J, Liu L, et al. Synthesis of poly-α/β-peptides with tunable sequence via the copolymerization on N-carboxyanhydride and N-thiocarboxyanhydride. iScience, 2021, 24: 10312410.1016/j.isci.2021.103124 ↗
41. Zhou M, Xiao X, Cong Z, et al. Water-insensitive synthesis of poly-β-peptides with defined architecture. Angew Chem Int Ed, 2020, 59: 7240–724410.1002/anie.202001697 ↗
42. Krumm C, Harmuth S, Hijazi M, et al. Antimicrobial poly(2-methyloxazoline)s with bioswitchable activity through satellite group modification. Angew Chem Int Ed, 2014, 53: 3830–383410.1002/anie.201311150 ↗
43. Dai C, Zhou M, Jiang W, et al. Breaking or following the membranetargeting mechanism: Exploring the antibacterial mechanism of host defense peptide mimicking poly(2-oxazoline)s. J Mater Sci Tech, 2020, 59: 220–22610.1016/j.jmst.2020.06.006 ↗
44. Zhou M, Jiang W, Xie J, et al. Peptide-mimicking poly(2-oxazoline)s displaying potent antimicrobial properties. ChemMedChem, 2021, 16: 309–31510.1002/cmdc.202000530 ↗
45. Zhou M, Qian Y, Xie J, et al. Poly(2-oxazoline)-based functional peptide mimics: Eradicating MRSA infections and persisters while alleviating antimicrobial resistance. Angew Chem Int Ed, 2020, 59: 6412–641910.1002/anie.202000505 ↗
46. Porter EA, Wang X, Lee HS, et al. Non-haemolytic β-amino-acid oligomers. Nature, 2000, 404: 56510.1038/35007145 ↗
47. Wu Y, Chen Y, Yu H, et al. Dual functional diblock amino acid copolymer displaying synergistic effect with curcumin against MRSA and encapsulation of curcumin. Chin J Chem, 2023, 41: 3333–333810.1002/cjoc.202300353 ↗
48. Li Y, Guo S, Li X, et al. Evaluation of the in vitro synergy of polymyxin B-based combinations against polymyxin B-resistant gram-negative bacilli. Microb Pathog, 2022, 166: 10551710.1016/j.micpath.2022.105517 ↗
49. Xiao X, Zhang S, Chen S, et al. An alpha/beta chimeric peptide molecular brush for eradicating MRSA biofilms and persister cells to mitigate antimicrobial resistance. BioMater Sci, 2020, 8: 6883–688910.1039/D0BM01211D ↗
50. Yasir M, Dutta D, Willcox MDP. Comparative mode of action of the antimicrobial peptide melimine and its derivative Mel4 against Pseudomonas aeruginosa. Sci Rep, 2019, 9: 706310.1038/s41598-019-42440-2 ↗
51. Sohlenkamp C, Geiger O, Narberhaus F. Bacterial membrane lipids: Diversity in structures and pathways. FEMS Microbiol Rev, 2016, 40: 133–15910.1093/femsre/fuv008 ↗